injection site reaction to tirzepatide Severe Injection site reaction -anyone else?

The widespread use of these drugs, combined with the fact that cancer is a leading cause of morbidity and mortality globally, necessitates a deeper understanding of how GLP-1 signaling might influence cancer risk and survival

Because GLP-1 medications slow stomach emptying and influence appetite signals, its common for people to experience some digestive discomfort, especially when first starting treatment or increasing their dosage

While some clinicians may prescribe both in select cases, the combination is not considered a standard weight-loss treatment and should always be evaluated on an individual basis with a licensed healthcare provider

About 9 to 12 months

Long-Term Safety Data on Extended Semaglutide Use Semaglutide has been used for type 2 diabetes management since 2017, providing over five years of real-world safety surveillance in millions of patients on extended therapy

All available safety information derives from regulated clinical trials conducted under investigational new drug frameworks, primarily sponsored by Eli Lilly and Company